Balfaxar
Payments companies reported to CMS as associated with Balfaxar. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Balfaxar, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Balfaxar
These are the largest totals companies reported as associated with Balfaxar. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $44,795.79 |
| Joseph Miller | Detroit, MI | Emergency Medicine | $19,695.99 |
| Gregory Simonian | Hackensack, NJ | Vascular Surgery | $6,196.99 |
| Jerrold Levy | Durham, NC | Anesthesiology | $5,912.15 |
| Carolyn Burns | Louisville, KY | Anatomic Pathology & Clinical Pathology | $5,000.00 |
| Ravindra Sarode | Dallas, TX | Blood Banking & Transfusion Medicine | $3,408.55 |
| Jonathan Jahr | Los Angeles, CA | Anesthesiology | $500.00 |
| Kenichi Tanaka | Oklahoma City, OK | Anesthesiology | $336.96 |
| John Mathew | Valley Stream, NY | Emergency Medicine | $276.86 |
| Christopher Raio | Manhasset, NY | Emergency Medicine | $276.86 |
Prescribed Balfaxar?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.